CS, C., MU, B., W, O., C, E., D, T., E, M., . . . JM, B. (2019). Presence and distribution of progerin in HGPS cells is ameliorated by drugs that impact on the mevalonate and mTOR pathways. Biogerontology, 20(3), 337. https://doi.org/10.1007/s10522-019-09807-4
Chicago Style (17th ed.) CitationCS, Clements, Bikkul MU, Ofosu W, Eskiw C, Tree D, Makarov E, Kill IR, and Bridger JM. "Presence and Distribution of Progerin in HGPS Cells Is Ameliorated by Drugs That Impact on the Mevalonate and MTOR Pathways." Biogerontology 20, no. 3 (2019): 337. https://doi.org/10.1007/s10522-019-09807-4.
MLA (9th ed.) CitationCS, Clements, et al. "Presence and Distribution of Progerin in HGPS Cells Is Ameliorated by Drugs That Impact on the Mevalonate and MTOR Pathways." Biogerontology, vol. 20, no. 3, 2019, p. 337, https://doi.org/10.1007/s10522-019-09807-4.